Announces Long-Range Targets Including 7% - 10% Revenue CAGR Through 2028 Highlights Clear Focus on Patient Outcomes, Technology Innovation and Commercial Execution IRVINE, Calif. / Dec 03, 2025 / Business Wire / Masimo (NASDAQ: MASI) today hosted its 2025 Investor Day at the Company’s headquarters. At the event, Masimo’s management team provided an update on the Company’s long-term strategy, including the pathway for... Read More

IRVINE, Calif. , Nov. 18, 2025 /PRNewswire/ -- A team from Knobbe Martens led medical device pioneer Masimo (NASDAQ: MASI) to a victory over Apple in a dispute involving Masimo's patented heart monitoring technology. Following an eight-day jury trial in the U.S. District Court for the Central District of California , a jury returned a verdict of patent infringement on all claims asserted, and awarded Masimo $634,313,913 in... Read More

IRVINE, Calif. / Nov 14, 2025 / Business Wire / Masimo (NASDAQ: MASI) today issued the following statement in response to the jury verdict announced in the U.S. District Court for the Central District of California, which confirmed the validity of Masimo Patent No. 10,433,776, found Apple infringed this patent, and awarded Masimo $634 million in damages: “We are pleased by this outcome, and appreciate the time and attention... Read More

IRVINE, Calif. / Nov 04, 2025 / Business Wire / Masimo Corporation (Nasdaq: MASI) today announced its financial results for the third quarter ended September 27, 2025. Third Quarter 2025 Results From Continuing Operations (1) : GAAP revenue of $371.5 million, representing 8.2% growth on a reported basis; Non-GAAP revenue of $371.2 million, representing 7.6% growth on a constant currency basis (2) ; GAAP net income per... Read More

Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) IRVINE, Calif. / Oct 21, 2025 / Business Wire / Masimo (NASDAQ: MASI) will release third quarter 2025 financial results for the period ended September 27, 2025, after the market closes on Tuesday, November 4, 2025. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Katie Szyman, Chief Executive Officer,... Read More

IRVINE, Calif. / Oct 09, 2025 / Business Wire / Masimo (NASDAQ: MASI) today announced it will host a meeting with the analyst and investor community at 9:00am PT on Wednesday, December 3, 2025. Presentations will be led by select members of the Executive Leadership Team and will cover an overview of the company’s business, market opportunities, innovation pipeline, commercial growth strategy, and long-term financial outlook.... Read More

The INSPIRE Trial Prospectively Assesses Pulse Oximeter Accuracy Using a Unique Real-world Study Design and in the Feasibility Study Showed No Clinically Significant Bias Between Patients with Light and Dark Skin Tones and No Occult Hypoxemia IRVINE, Calif. / Oct 07, 2025 / Business Wire / Masimo (NASDAQ: MASI) today announced the findings of an exploratory analysis for a unique feasibility study published in CHEST Critical... Read More

IRVINE, Calif. / Sep 23, 2025 / Business Wire / Masimo (NASDAQ: MASI) today announced it has completed the previously announced sale of its Sound United consumer audio business to HARMAN International (“HARMAN”), a wholly-owned subsidiary of Samsung Electronics Co., Ltd. Katie Szyman, Chief Executive Officer of Masimo, stated, “The completion of the Sound United sale is an important milestone in our ongoing efforts to focus... Read More

Universal Surveillance Monitoring with Masimo SET ® Pulse Oximetry and Patient SafetyNet™ – Repeatedly Shown to Improve Patient Outcomes and Save Lives – Also Projected to Yield Significant Cost Savings IRVINE, Calif. / Sep 17, 2025 / Business Wire / Masimo (NASDAQ: MASI) today announced the findings of a study published in the Journal of Patient Safety in which Dr. George Blike and colleagues at Dartmouth-Hitchcock Medical... Read More

Multi-Year Partnership Renewal with Broadened Focus Will Include Expedited Technology Adoption and Market-Based Strategic Development of Next-Generation Monitoring Solutions IRVINE, Calif. / Sep 11, 2025 / Business Wire / Masimo (NASDAQ: MASI) today announced a multi-year renewal and expansion of its strategic partnership with Royal Philips (NYSE: PHG, AEX: PHIA). Building on over two decades of collaboration, this... Read More

IRVINE, Calif. / Aug 28, 2025 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the Wells Fargo Healthcare Conference on Thursday, Sept 4, 2025 at 1:30 p.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a... Read More

Now Available for Both Cerebral and Somatic Applications and for All Patient Populations, O3’s Delta Hemoglobin Parameters Offer Clinicians Additional Insight Into Changes in Tissue Oxygen Saturation IRVINE, Calif. / Aug 19, 2025 / Business Wire / Masimo (NASDAQ: MASI) today announced the FDA 510(k) clearance of expanded indications for the delta hemoglobin parameters provided with O3 ® Regional Oximetry . The parameters... Read More

IRVINE, Calif. / Aug 05, 2025 / Business Wire / Masimo Corporation (Nasdaq: MASI) today announced its financial results for the second quarter ended June 28, 2025. Second Quarter 2025 Results From Continuing Operations (1) : GAAP revenue of $371 million, representing 8% growth on a reported basis; Non-GAAP revenue of $370 million, representing 7% growth on a constant currency basis (2) ; GAAP net income per diluted share of... Read More

Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) IRVINE, Calif. / Jul 22, 2025 / Business Wire / Masimo (NASDAQ: MASI) will release second quarter 2025 financial results for the period ended June 28, 2025, after the market closes on Tuesday, August 5, 2025. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Katie Szyman, Chief Executive Officer, and... Read More

American Heart Association Consortium Advances Development of Evidence-based Health Tech Solutions IRVINE, Calif. / Jul 08, 2025 / Business Wire / Masimo (NASDAQ: MASI), a global medical technology company that develops and manufactures innovative noninvasive monitoring solutions, has joined the American Heart Association Center for Health Technology & Innovation’s (the Center) Innovators’ Network. The Center is focused on... Read More

EEG-Guided Anesthesia Using Masimo Technology Significantly Reduced Pediatric Anesthesia Emergence Delirium, Time to Emergence and Discharge, and Cost of Care by Minimizing Sevoflurane Exposure NEUCHATEL, Switzerland / Jun 10, 2025 / Business Wire / Masimo (NASDAQ: MASI) today announced the findings of a randomized clinical trial published in JAMA Pediatrics in which Dr. Yasuko Nagasaka and colleagues at Tokyo Women’s... Read More

IRVINE, Calif. / May 27, 2025 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies Global Healthcare Conference on Wednesday, June 4, 2025 at 1:25 p.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI)... Read More

IRVINE, Calif. / May 07, 2025 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025 at 4:20 p.m. Pacific time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ:... Read More

IRVINE, Calif. / May 06, 2025 / Business Wire / Masimo Corporation (Nasdaq: MASI) today announced its financial results for the first quarter ended March 29, 2025. First Quarter 2025 Results From Continuing Operations (1) : GAAP revenue of $372 million, representing 10% on a reported basis; Non-GAAP revenue of $371 million, representing 10% on a constant currency basis (3) ; GAAP net income per diluted of $0.86; and Non-GAAP... Read More

Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) IRVINE, Calif. / Apr 24, 2025 / Business Wire / Masimo (NASDAQ: MASI) will release first quarter 2025 financial results for the period ended March 29, 2025, after the market closes on Tuesday, May 6, 2025. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Katie Szyman, Chief Executive Officer, and Micah... Read More

IRVINE, Calif. / Apr 02, 2025 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025 at 2:15 p.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo... Read More

IRVINE, Calif. / Feb 28, 2025 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the 46th Annual Raymond James Institutional Investor Conference on Tuesday, March 4, 2025 at 11:35 a.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo... Read More

IRVINE, Calif. / Feb 25, 2025 / Business Wire / Masimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and full-year ended December 28, 2024 and provided updated estimates for its full-year 2025 guidance. Fourth Quarter 2024 Financial Results: Consolidated revenue was $601 million, representing 9% growth on a reported and constant currency basis (1) ; Healthcare revenue was $368 million,... Read More

Katie Szyman Appointed Chief Executive Officer and to Board of Directors Interim CEO Michelle Brennan Named Chairman of Masimo’s Board IRVINE, Calif. / Jan 21, 2025 / Business Wire / Today the Board of Directors (the “Board”) of Masimo (NASDAQ: MASI), a leading global medical innovator, announced that Katie Szyman has been appointed the next Chief Executive Officer (“CEO”) of the Company. Interim CEO Michelle Brennan has... Read More

Complete fourth quarter and full-year 2024 financial results will be announced on Tuesday, February 25, 2025 IRVINE, Calif. / Jan 16, 2025 / Business Wire / Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ended December 28, 2024 and provided estimates for its full-year 2025 guidance. Preliminary Fourth Quarter 2024 Financial Results: Consolidated... Read More

IRVINE, Calif. / Jan 09, 2025 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 10:30 a.m. Pacific time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo... Read More

IRVINE, Calif. / Nov 26, 2024 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024 at 8:30 a.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo... Read More

IRVINE, Calif. / Nov 14, 2024 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies London Healthcare Conference on Thursday, November 21, 2024 at 8:30 a.m. GMT. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a... Read More

IRVINE, Calif. / Nov 13, 2024 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the Stifel 2024 Healthcare Conference on Monday, November 18, 2024 at 11:30 a.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is... Read More

Third Quarter 2024 Highlights: Healthcare revenue of $343.3 million increased 11.5% on a reported basis and 11.7% on a constant currency basis (1) ; GAAP net income per diluted share was $0.18; and Non-GAAP (1) net income per diluted share was $0.98. IRVINE, Calif. / Nov 05, 2024 / Business Wire / Masimo Corporation (Nasdaq: MASI) today announced its financial results for the third quarter ended September 28, 2024. Third... Read More

Renowned Healthcare Facility Launches Advanced Wireless Monitoring Technology in the Emergency Department, Reducing Wait Times and Improving Patient Prioritization IRVINE, Calif. / Oct 29, 2024 / Business Wire / Masimo (NASDAQ: MASI) today announced that Vanderbilt University Medical Center (VUMC) , a renowned healthcare... Read More

Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) IRVINE, Calif. / Oct 22, 2024 / Business Wire / Masimo (NASDAQ: MASI) will release third quarter 2024 financial results for the period ended September 28, 2024, after the market closes on Tuesday, November 5, 2024. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Michelle Brennan, interim Chief... Read More

Mr. Scannell and Ms. Lane will Add Valuable Medical Technology, Finance and Corporate Governance Experience to Expanded Eight-Member Board IRVINE, Calif. / Oct 18, 2024 / Business Wire / Masimo Corporation (Nasdaq: MASI), a leading global medical innovator, today announced the appointments of Timothy J. Scannell and Wendy E. Lane to the Company’s Board of Directors (the “Board”), effective immediately. Following these... Read More

Appoints Michelle Brennan as Interim CEO Following Joe Kiani’s Decision to Resign Continues to Be Committed to Review of Strategic Alternatives for Consumer Businesses, With Assistance From Leading Financial and Legal Advisors Reaffirms Financial Guidance for Third Quarter 2024 IRVINE, Calif. / Sep 25, 2024 / Business Wire / Today the Board of Directors (the “Board”) of Masimo (Nasdaq: MASI) a leading global medical... Read More

Details How Independent Third Parties and the Evidence in Legal Proceedings Have Consistently Refuted Masimo’s “Defensive Rhetoric” and How Company’s Attacks on Politan Continue to “Crumble Under Basic Scrutiny” Shareholders Can Vote for Politan’s Independent Nominees, Darlene Solomon and William Jellison, on the WHITE Card and Can Visit www.AdvanceMasimo.com for Further Information NEW YORK / Sep 16, 2024 / Business Wire /... Read More

IRVINE, Calif. / Sep 15, 2024 / Business Wire / Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today is sharing a summary of the core issues to consider in this contest for control of the Masimo Board and urging stockholders to vote “FOR” only Masimo’s Director Nominees, Joe Kiani and Christopher Chavez, on the updated GOLD proxy card.... Read More

Comprehensive Platform Combines Masimo’s Industry-leading Biosensing Capabilities with Snapdragon Wearable Platforms to Expand the Wear OS by Google™ Ecosystem IRVINE, Calif. / Sep 14, 2024 / Business Wire / Masimo (NASDAQ: MASI), a leading global medical innovator, and Qualcomm Technologies, Inc. , whose Snapdragon ® branded... Read More

Comprehensive Smartwatch Reference Platform to Include Key Hardware and Software Components, Including Industry-leading Masimo Biosensing Capabilities IRVINE, Calif. / Sep 13, 2024 / Business Wire / Masimo (NASDAQ: MASI), a leading global medical innovator, today announced a partnership with Google to develop a new reference... Read More

Finding of Contempt is an Extraordinary and Severe Remedy Court Finds Politan’s False Statements Improperly Influenced ISS and Glass Lewis Recommendations; Egan-Jones Recommends “FOR” Both of Masimo’s Director Nominees Following Multiple Corrective Disclosures by Politan Court States a Reasonable Stockholder Would Consider Politan’s and Quentin Koffey’s Contempt when Evaluating Proxy Vote IRVINE, Calif. / Sep 13, 2024 /... Read More

In Its Report, Egan-Jones States, “…losing Mr. Kiani who has a pivotal role in innovation and change, would impair Masimo’s reputation and the interests of the shareholders…” Egan-Jones is the Sole Proxy Advisory Firm to Issue Its Recommendation Following Access to and Review of Post-Litigation Discovery Facts & Politan’s Corrections IRVINE, Calif. / Sep 12, 2024 / Business Wire / Masimo Corporation (“Masimo” or the... Read More

ISS and Glass Lewis Based Recommendations Upon Politan’s Lies; Egan-Jones Recommends “FOR” Both of Masimo’s Director Nominees Following Multiple Corrective Disclosures by Politan Control of Masimo Depends on September 19 Vote – Stockholders Urged to Vote “FOR” Only Masimo’s Director Nominees, Joe Kiani and Christopher Chavez, on the Updated GOLD Proxy Card IRVINE, Calif. / Sep 12, 2024 / Business Wire / Masimo Corporation... Read More

Stockholders are Urged to Vote “FOR” Only Masimo’s Director Nominees, Joe Kiani and Christopher Chavez, on the Updated GOLD Proxy Card IRVINE, Calif. / Sep 09, 2024 / Business Wire / Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today mailed a letter to stockholders in connection with its upcoming Annual Meeting of Stockholders (the... Read More

Leading French Healthcare Facility Adopts an Innovative Telemonitoring Platform as Part of a Mobile Neonatology Unit for the Monitoring of Premature Newborns, Serving Both Patients and Caregivers NEUCHATEL, Switzerland / Sep 09, 2024 / Business Wire / Masimo (NASDAQ: MASI) today announced that Saint-Denis Hospital Center is... Read More

Shares Details From Recently Unredacted Legal Filings About Quentin Koffey’s Multi-Year Plan to Take Control of Masimo IRVINE, Calif. / Sep 03, 2024 / Business Wire / Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today mailed a letter to stockholders in connection with its upcoming Annual Meeting of Stockholders (the “Annual Meeting”)... Read More

IRVINE, Calif. / Aug 29, 2024 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the Wells Fargo Healthcare Conference on Thursday, September 5, 2024 at 10:15 a.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (Nasdaq: MASI)... Read More

Company to Donate $100,000 of Stork™ Smart Home Baby Monitoring Systems and Take Part in a March of Dimes Donation Matching Program IRVINE, Calif. / Aug 27, 2024 / Business Wire / Masimo (NASDAQ: MASI), a global leader in innovative monitoring technologies used in top hospitals, and March of Dimes, the leading non-profit... Read More

Highlights Risk to Continued Momentum and Innovation if Politan Gains Board Control Urges Stockholders to Vote “FOR” Only Masimo’s Director Nominees, Joe Kiani and Christopher Chavez, on the Updated GOLD Proxy Card IRVINE, Calif. / Aug 26, 2024 / Business Wire / Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a... Read More

Masimo SET ® Is the Primary Pulse Oximetry at All 10 Top U.S. Hospitals, Monitors More Than 200 Million Patients a Year, and Has Been Shown to Have Unrivaled Accuracy and Reliability in More Than 100 Clinical Studies IRVINE, Calif. / Aug 26, 2024 / Business Wire / Masimo (NASDAQ: MASI) Signal Extraction Technology ® , or SET ®... Read More

Files Revised Definitive Proxy Materials and Mails Letter to Stockholders Urges Stockholders to Vote “FOR” Only Masimo’s Director Nominees, Joe Kiani and Christopher Chavez, on the Updated GOLD Proxy Card IRVINE, Calif. / Aug 15, 2024 / Business Wire / Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today announced that it has filed... Read More

Secure Bluetooth ® Connectivity Allows Continuous, Accurate Wrist-based Measurements to be Seamlessly Relayed to Caregivers via the Masimo Secure Health Data Cloud IRVINE, Calif. / Aug 12, 2024 / Business Wire / Masimo (NASDAQ: MASI) today announced that the Masimo W1 ® medical watch has received FDA 510(k) clearance for... Read More

Second Quarter 2024 Highlights: Consolidated revenue was $496.3 million; Healthcare revenue was $343.9 million; Non-healthcare revenue was $152.4 million; GAAP net income per diluted share was $0.29; and Non-GAAP net income per diluted share was $0.86. IRVINE, Calif. / Aug 06, 2024 / Business Wire / Masimo Corporation (Nasdaq: MASI) today announced its financial results for the second quarter ended June 29, 2024. Second... Read More

IRVINE, Calif. / Jul 29, 2024 / Business Wire / Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the Journal of Orthopaedics in which Dr. Michael DeRogatis and colleagues at St. Luke’s University Health Network (SLUHN) in Pennsylvania, joined by researchers at several additional... Read More

Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) IRVINE, Calif. / Jul 24, 2024 / Business Wire / Masimo (NASDAQ: MASI) will release second quarter 2024 financial results for the period ended March 30, 2024, after the market closes on Tuesday, August 6, 2024. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive... Read More

IRVINE, Calif. / Jul 16, 2024 / Business Wire / Masimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI), a global leader in noninvasive monitoring technologies and audio products, today announced that it has commenced litigation against Politan Capital Management LP (“Politan”) in federal court in California seeking to require Politan to correct material misstatements and omissions in Politan’s proxy materials. The... Read More

IRVINE, Calif. / Jul 15, 2024 / Business Wire / To ensure that Politan lies repeated over and over are not taken as fact, Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI) sets forth below facts in response to what we believe are some of Politan’s and Quentin Koffey’s most egregious and continuing misrepresentations. These misrepresentations include Politan’s and Mr. Koffey’s continuing efforts to sow mistrust... Read More

Believes that Masimo’s Current Board Prioritizes Unquestioning Loyalty to Mr. Kiani Above All Else – Making Real Independent Oversight Impossible Highlights How a Majority of Truly Independent Directors Can Benefit Masimo’s Patients, Employees and Shareholders and Unlock the Company’s Growth Potential NEW YORK / Jul 11, 2024 / Business Wire / Politan Capital Management (together with its affiliates, “Politan”), an 8.9%... Read More

Highlights Quentin Koffey’s Actions That Have Flown in the Face of Good Governance IRVINE, Calif. / Jul 11, 2024 / Business Wire / Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI) today highlighted the actions taken by Politan and Quentin Koffey since Masimo’s 2023 Annual Meeting of Stockholders that directly contradict their purported commitment to good governance. Over the past twelve months, we believe... Read More

IRVINE, Calif / Jul 09, 2024 / Business Wire / Masimo Corporation (Nasdaq: MASI) today announced preliminary revenue and select financial results for the second quarter ended June 29, 2024. Preliminary Second Quarter 2024 Revenue and Select Financial Results: Consolidated revenue is expected to be approximately $496 million, representing 9% growth on a reported basis and 10% growth on a constant currency basis; Healthcare... Read More

IRVINE, Calif. / Jul 02, 2024 / Business Wire / Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI) today issued the following statement to address what Masimo strongly believes is Politan’s campaign of deception and distraction to deflect attention from its own failures and its nominees’ shortcomings. The Company urges investors to choose Masimo’s commitment to transparency and value creation over what it believes... Read More

Chavez’s Independence Stands in Stark Contrast to Politan’s Paid and Handpicked Nominees IRVINE, Calif. / Jul 01, 2024 / Business Wire / Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI) today issued a letter to stockholders in connection with the Company’s 2024 Annual Meeting of Stockholders. The letter highlights the fierce independence and deep medtech experience of nominee Christopher Chavez and contrasts it... Read More

Sleep Halo Sleep Metrics Are Based on Masimo W1’s Continuous Pulse Oximetry Measurements and Advanced Halo AI Technology IRVINE, Calif. / Jul 01, 2024 / Business Wire / Masimo (NASDAQ: MASI), today announced that the Masimo W1 ® Sport advanced health tracking wearable is gaining a powerful new feature: scientifically based... Read More

IRVINE, Calif. & CLEVELAND / Jun 27, 2024 / Business Wire / Masimo (NASDAQ: MASI), a leading global provider of medical technology and hospital automation solutions, and Cleveland Clinic , a nonprofit academic medical center, announced today the launch of a new partnership centered around hospital-based remote patient... Read More

Masimo’s Strategy Capitalizes on Innovation to Enhance Growth and Create Value for All Stockholders Politan is Making a Bid for Control Without Paying a Premium or Articulating a Clear Plan Politan is Seeking to Replace Masimo Founder, Chairman and CEO Joe Kiani with Inferior Politan Nominees Politan’s Actions are a Threat to Stockholder Value Masimo Has a Better Plan and Better Nominees Strongly Encourages Stockholders to... Read More

IRVINE, Calif. , June 24, 2024 /PRNewswire/ -- Knobbe Martens secured another victory for Masimo Corporation (NASDAQ: MASI) with the successful dismissal with prejudice of a patent infringement lawsuit filed by Wrist SP Biotech, a non-practicing entity (NPE). This success is the latest in a string of successful results Knobbe Martens has achieved for Masimo. In August 2023 Wrist SP filed a complaint in the Western District... Read More

IRVINE, Calif. / Jun 20, 2024 / Business Wire / Masimo (NASDAQ: MASI) today issued the following statement to set the record straight regarding Politan’s “Background of the Solicitation” section of its proxy statement issued in connection with Masimo’s upcoming Annual Meeting of Stockholders. Masimo strongly believes Politan is providing investors with inaccurate and incomplete information, as Masimo Founder, Chairman and... Read More

Strongly Encourages Stockholders to Vote FOR Joe Kiani and Christopher Chavez on the GOLD Proxy Card Warns Stockholders of Politan’s Value-Destructive Agenda Should It Gain Control Highlights Masimo’s Track Record of Innovation, Longstanding Premium Valuation, Strong Long-Term Plan and Superior Director Nominees Visit... Read More

IRVINE, Calif. / Jun 06, 2024 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024 at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo... Read More

Collaborative Partnership Designed to Enhance Nationwide Efforts to Combat the Opioid Epidemic and Improve Addiction Recovery IRVINE, Calif. / Jun 05, 2024 / Business Wire / Masimo (NASDAQ: MASI), a leading global medical technology innovator, today announced that it is partnering with Mobilize Recovery , a nonprofit... Read More

Scope of the SESHAT Project at Pioneering Hospital, Part of the Catalan Health Institute, Includes Deployment of up to 1,000 Masimo W1 Watches, 100 Radius VSMs, and Numerous Additional Masimo Hospital Automation™ Solutions BARCELONA, Spain / Jun 03, 2024 / Business Wire / Masimo (NASDAQ: MASI) today announced that Germans... Read More

Experienced Medical Device Executive Christopher Chavez to Stand for Election at 2024 Annual Meeting Company Extends Third Settlement Offer to Politan; Politan Again Rejects Offer IRVINE, Calif. / May 31, 2024 / Business Wire / Masimo (NASDAQ: MASI) announced today that its Board of Directors has nominated Christopher Chavez for election as a Class II Director at the Company’s 2024 Annual Meeting of Stockholders. Following... Read More

IRVINE, Calif. / May 29, 2024 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies Global Healthcare Conference on Wednesday, June 5, 2024 at 1:00 p.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (Nasdaq: MASI)... Read More

Masimo Becomes First Pulse Oximetry Manufacturer to be Recognized with Coveted “Greenhealth Approved” Seal IRVINE, Calif. & RESTON, Va. / May 20, 2024 / Business Wire / Masimo (NASDAQ: MASI), a leading medical technology innovator, and Practice Greenhealth , a prominent organization dedicated to advancing sustainability... Read More

IRVINE, Calif. / May 08, 2024 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the BofA Securities Health Care Conference on Wednesday, May 15, 2024 at 4:20 p.m. Pacific Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (Nasdaq: MASI)... Read More

First Quarter 2024 Highlights: Consolidated revenue was $492.8 million; Healthcare revenue was $339.6 million; Non-healthcare revenue was $153.2 million; GAAP net income per diluted share was $0.35; and Non-GAAP net income per diluted share was $0.77. IRVINE, Calif. / May 07, 2024 / Business Wire / Masimo Corporation (Nasdaq: MASI) today announced its financial results for the first quarter ended March 30, 2024. First... Read More

With This Clearance, Stork Provides Continuous Monitoring of Oxygen Saturation, Pulse Rate, and Skin Temperature, with Alarms, for Babies up to 18 Months, at Home, Without a Prescription IRVINE, Calif. / May 06, 2024 / Business Wire / Masimo (NASDAQ: MASI), a global leader in innovative monitoring technologies currently... Read More

Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) IRVINE, Calif. / Apr 23, 2024 / Business Wire / Masimo (NASDAQ: MASI) will release first quarter 2024 financial results for the period ended March 30, 2024, after the market closes on Tuesday, May 7, 2024. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer,... Read More

Kiani’s Speech on Wednesday, at the 6 th Global Ministerial Summit on Patient Safety, Will Explore How AI-Based Medical Solutions Can Empower Clinicians and Improve Patient Safety SANTIAGO, Chile / Apr 16, 2024 / Business Wire / Masimo (NASDAQ: MASI) today announced that its Founder and CEO, Joe Kiani, will be a featured speaker tomorrow, April 17, at the 6 th Global Ministerial Summit on Patient Safety. Kiani’s speech,... Read More

Politan’s Efforts to Take Control of Masimo Are Not in Stockholders’ Best Interests IRVINE, Calif. / Apr 01, 2024 / Business Wire / Masimo (NASDAQ: MASI) today confirmed that Politan Capital Management LP (“Politan”) has provided notice of its intent to nominate two candidates to stand for election to the Masimo Board of Directors at the company’s 2024 Annual Meeting. While Masimo respects and values the input and ideas of... Read More

IRVINE, Calif. / Mar 22, 2024 / Business Wire / Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today announced that its Board of Directors has authorized management to evaluate a proposed separation of its consumer business. The Board and management will evaluate the proposed structure of the separation. Masimo expects that the separation will include its consumer audio and... Read More

IRVINE, Calif. / Mar 19, 2024 / Business Wire / Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, is thrilled to announce its recognition as one of Fast Company’s Most Innovative Companies in North America for 2024. This prestigious accolade is especially meaningful given... Read More

IRVINE, Calif. / Mar 04, 2024 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the 45th Annual Raymond James Institutional Investors Conference on Tuesday, March 5, 2024 at 3:25 p.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo... Read More

Fourth Quarter 2023 Highlights: Consolidated revenue was $548.9 million; Healthcare revenue was $339.9 million; Non-healthcare revenue was $209.0 million; GAAP net income per diluted share of $0.63; and Non-GAAP net income per diluted share (updated definition) of $1.25. Full-Year 2023 Highlights: Consolidated revenue was $2,048.1 million; Healthcare revenue was $1,275.5 million; Non-healthcare revenue was $772.6 million.... Read More

IRVINE, Calif. & DENVER / Feb 20, 2024 / Business Wire / Masimo (NASDAQ: MASI), a leading global provider of medical technology and automation solutions, and UCHealth , a nationally recognized network of hospitals, clinics, and providers based in Colorado, announced today that they are entering into a strategic collaboration to improve the standard of patient care using the latest in virtual care and telehealth capabilities.... Read More

Masimo MightySat ® Medical Provides Clinically Proven Masimo SET ® Pulse Oximetry to Consumers for Medical Use Without a Prescription IRVINE, Calif. / Feb 13, 2024 / Business Wire / Masimo (NASDAQ: MASI) announced today FDA clearance of MightySat ® Medical, making it the first and only FDA-cleared medical fingertip pulse... Read More

IRVINE, Calif. / Feb 08, 2024 / Business Wire / Masimo (NASDAQ: MASI) today announced the findings of a retrospective, peer-reviewed study published in the Journal of Clinical Monitoring and Computing in which Dr. Vikrant Sharma, along with Dr. Steven J. Barker, Dr. William C. Wilson, and colleagues at Masimo performed a... Read More

IRVINE, Calif. / Jan 17, 2024 / Business Wire / Masimo ( NASDAQ: MASI), a global leader in innovative noninvasive monitoring technologies, welcomes the Federal Circuit’s ruling to lift the temporary stay on the import ban of certain Apple Watch models. This decision reinstates the U.S. International Trade Commission’s import... Read More

Bob Chapek Joins Masimo’s Board of Directors IRVINE, Calif. / Jan 16, 2024 / Business Wire / Masimo (NASDAQ: MASI) announced today that Bob Chapek has been appointed to Masimo’s Board of Directors. Mr. Chapek was Chief Executive Officer of The Walt Disney Company, one of the world’s largest media and entertainment companies, from February 2020 to November 2022, successfully leading Disney through the global COVID-19 pandemic... Read More

Complete fourth quarter and full-year 2023 financial results will be announced on Tuesday, February 27, 2024 IRVINE, California / Jan 10, 2024 / Business Wire / Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ended December 30, 2023 and provided estimates for its full-year 2024 guidance. Preliminary Fourth Quarter 2023 Financial Results: •... Read More

Stork Provides Continuous Monitoring of Oxygen Saturation, Pulse Rate, and Skin Temperature, with Alarms, for Sick and Healthy Babies at Home IRVINE, Calif. / Dec 18, 2023 / Business Wire / Masimo (NASDAQ: MASI), a global leader in innovative monitoring technologies used in top hospitals, announced today FDA clearance of... Read More

In the Largest Study of ORi to Date, of 554 Patients, Researchers Conclude: “ORi Can Provide Useful Information on Arterial Oxygenation Even During One-Lung Ventilation” NEUCHATEL, Switzerland / Dec 11, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced the findings of a retrospective study published in the Journal... Read More

IRVINE, Calif. / Nov 27, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023 at 9:30 am ET. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (Nasdaq:... Read More

IRVINE, Calif. / Nov 17, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that the Masimo W1™ medical watch has received FDA 510(k) clearance for over-the-counter (OTC) and prescription use (Rx). Masimo W1 is the first FDA-cleared watch to provide continuous real-time oxygen saturation (SpO 2 ) and pulse rate (PR)... Read More

IRVINE, Calif. / Nov 09, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies London Healthcare Conference on Wednesday, November 15, 2023 at 3:00 pm GMT. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (Nasdaq: MASI) is a... Read More

CHICAGO & IRVINE, Calif. / Nov 08, 2023 / Business Wire / GE HealthCare (Nasdaq: GEHC) and Masimo (Nasdaq: MASI) today announced a joint agreement to integrate Masimo Signal Extraction Technology ® (SET ® ) pulse oximetry into GE HealthCare’s Portrait Mobile wireless and wearable patient monitoring solution. Portrait Mobile is built as an Internet of Medical Things (IoMT) platform, using the latest cloud native technology to... Read More

Rolf A. Classon Joins Masimo’s Board of Directors IRVINE, Calif. / Nov 07, 2023 / Business Wire / Masimo (NASDAQ: MASI) announced today that Rolf A. Classon has been appointed to Masimo’s Board of Directors. Mr. Classon is an experienced medical technology executive and board member. From October 2002 until his retirement in July 2004, he was Chairman of the Executive Committee of Bayer HealthCare AG. He served as President... Read More

Third Quarter 2023 Highlights Consolidated revenue was $478.9 million; Healthcare revenue was $307.8 million; Non-healthcare revenue was $171.1 million; GAAP net income per diluted share was $0.20; and Non-GAAP net income per diluted share was $0.63. IRVINE, Calif. / Nov 07, 2023 / Business Wire / Masimo Corporation (Nasdaq: MASI) today announced its financial results for the third quarter of 2023, ended September 30, 2023.... Read More

Decision Holds World’s Largest Company Accountable for Its Patent Infringement WASHINGTON / Oct 26, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that the United States International Trade Commission (USITC) has recommended a limited exclusion order for infringing Apple Watches with light-based pulse oximetry functionality. The USITC found that Apple (NASDAQ: AAPL) violated U.S. laws by incorporating Masimo’s... Read More

Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) IRVINE, Calif. / Oct 24, 2023 / Business Wire / Masimo (NASDAQ: MASI) will release third quarter 2023 financial results for the period ended September 30, 2023, after the market closes on Tuesday, November 7, 2023. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive... Read More

ORi to Be Launched in the U.S. at ANESTHESIOLOGY 2023 This Weekend SAN FRANCISCO / Oct 13, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that ORi™, a noninvasive, continuous parameter designed to provide additional insight into a patient’s oxygen status in the moderate hyperoxic range under supplemental oxygen,... Read More

LiDCO Offers Clinicians, for the First Time, a Board-in-Cable Solution Designed to Provide a More Complete Picture of Oxygen Delivery NEUCHATEL, Switzerland / Oct 09, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced the CE mark, under the European Union Medical Device Regulation, for the LiDCO ® board-in-cable... Read More

IRVINE, Calif. / Sep 07, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the Wells Fargo Healthcare Conference on Friday, September 8, 2023 at 9:30 a.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (Nasdaq: MASI) is... Read More

Leading Louisiana and Mississippi Healthcare Provider Standardizes 10 Hospitals on Masimo SET ® and Patient SafetyNet™ to Enhance Patient Safety and Improve Patient Outcomes IRVINE, Calif. / Aug 31, 2023 / Business Wire / Masimo (NASDAQ: MASI) and Franciscan Missionaries of Our Lady Health System (FMOLHS) , a 10-hospital... Read More

IRVINE, Calif. / Aug 23, 2023 / Business Wire / Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies, today announced the full U.S. market release of the Stork smart home baby monitoring system. Stork Vitals+, Vitals, and Camera combinations are now available for purchase online at www.MasimoStork.com... Read More

Researchers Found That Fluid Therapy Guided by Noninvasive, Continuous PVi Reduced Cardiopulmonary Complications and Fluid Administered NEUCHATEL, Switzerland / Aug 21, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced the findings of a prospective, randomized study published in Perioperative Medicine in which Dr.... Read More

Second Quarter 2023 Highlights Consolidated revenue was $455.3 million; Healthcare revenue was $281.1 million; Non-healthcare revenue was $174.2 million; GAAP net income per diluted share was $0.29; and Non-GAAP net income per diluted share was $0.62. IRVINE, Calif. / Aug 08, 2023 / Business Wire / Masimo Corporation (Nasdaq: MASI) today announced its financial results for the second quarter of 2023, ended July 1, 2023.... Read More

Masimo PSi, a Processed EEG Parameter, “Better Captured” Changes in Brain State Compared to Other Assessment Methods IRVINE, Calif. / Aug 07, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced the findings of a study published in Frontiers in Neuroscience in which Dr. Lichy Han and colleagues at Stanford University... Read More

Management to announce and discuss complete second quarter 2023 financial results on Tuesday, August 8, 2023. IRVINE, Calif. / Jul 17, 2023 / Business Wire / Masimo Corporation (Nasdaq: MASI) today announced preliminary revenue results for the second quarter ended July 1, 2023. Preliminary Second Quarter 2023 Revenue Results... Read More

Appreciates Support From Fellow Shareholders Demonstrating Clear Mandate For Change Nominees Michelle Brennan and Quentin Koffey Are Ready to Work Constructively in the Masimo Boardroom to Benefit All Stakeholders NEW YORK / Jun 26, 2023 / Business Wire / Politan Capital Management (together with its affiliates, “Politan”), a 9% shareholder of Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), today commented on... Read More

Top Spanish Hospital Builds on the Success of Its Postoperative Telemonitoring Program with Masimo SafetyNet ® NEUCHATEL, Switzerland / Jun 22, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that Hospital La Fe in Valencia, Spain, is expanding its telehealth and telemonitoring program with the Masimo W1™ advanced... Read More

Roundtable, which included a special fireside chat with Masimo Founder & Chairman Joe Kiani and President Bill Clinton, held at Clinton Foundation offices in New York City Participants included national leaders in healthcare, education, and policy NEW YORK / Jun 21, 2023 / Business Wire / Masimo (NASDAQ: MASI) and the Clinton... Read More

Vote the WHITE Proxy Card Today Visit KeepMasimoStrong.com for More Information IRVINE, Calif. / Jun 20, 2023 / Business Wire / The Board of Directors of Masimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI) today issued a letter to stockholders in connection with the Company’s Annual Meeting of Stockholders to be held... Read More

IRVINE, Calif. / Jun 20, 2023 / Business Wire / Masimo (NASDAQ: MASI), a leading developer of medical technology solutions and consumer health and audio devices, is expanding its premium Denon brand to introduce its latest innovation, Masimo AAT™ (Adaptive Acoustic Technology™). Denon PerL™ and PerL Pro™ True Wireless (TWS)... Read More

Emphasizes Track Record of Innovation Powering Growth, Stockholder Value Creation Under Joe Kiani’s Leadership Illuminates Risk Quentin Koffey Poses to Masimo’s Culture of Innovation Strongly Encourages Stockholders to Protect Their Investment by Voting FOR H Michael Cohen and Julie Shimer, Ph.D., on the WHITE Proxy Card Visit... Read More

Premier Central Valley Provider Adopts Masimo SET ® , Root ® , Rad-97 ® , and Much More Across Multiple Hospitals IRVINE, Calif. / Jun 12, 2023 / Business Wire / Masimo (NASDAQ: MASI) and Community Health System (CHS) , based in Fresno, California, today announced that CHS is adopting a variety of advanced Masimo monitoring... Read More

NEUCHATEL, Switzerland / Jun 08, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that the Department of Anesthesiology at the Lausanne University Hospital (CHUV) , one of Switzerland’s premier academic institutions, has chosen to make the Masimo W1™ advanced health tracking watch a key part of its pre-surgical... Read More

Mr. Kiani Previously Waived Other Rights in Connection with the 2023 Annual Meeting of Stockholders and the Appointment of a Lead Independent Director IRVINE, Calif. / Jun 06, 2023 / Business Wire / Masimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI) today announced that Joe Kiani, founder, Chairman and Chief Executive Officer of Masimo, unconditionally, irrevocably and permanently waived his right to assert that a... Read More

IRVINE, Calif. / Jun 05, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies Healthcare Conference on Thursday, June 8, 2023 at 11:00 a.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (Nasdaq: MASI) is a... Read More

Transformational, Versatile, Patient-worn, Continuous Vital Signs Monitor Features Wide Range of Physiological Measurements on a Compact, Scalable Platform IRVINE, Calif. / Jun 05, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that Radius VSM™ , a patient-worn, continuous multi-parameter vital signs monitor, has... Read More

Commitment to Appoint Politan Nominee as Director Reflects Board’s Openness to Qualified and Experienced Perspectives Board Strongly Encourages Stockholders to Protect Their Investment by Voting FOR H Michael Cohen and Julie Shimer, Ph.D., and FOR Board Expansion on the WHITE Proxy Card IRVINE, Calif. / Jun 02, 2023 / Business Wire / On June 2, 2023, Masimo Corporation (“Masimo”) issued the following press release in... Read More

Commitment to Appoint Politan Nominee as Director Reflects Board’s Openness to Qualified and Experienced Perspectives Stockholders Do Not Need to Vote for Ms. Brennan to Add Her to Board Board Strongly Encourages Stockholders to Protect Their Investment by Voting FOR H Michael Cohen and Julie Shimer, Ph.D., and FOR Board Expansion on the WHITE Proxy Card IRVINE, Calif. / Jun 02, 2023 / Business Wire / The Board of Directors... Read More

Responds and Corrects Politan’s Inaccurate Letter Highlights Politan’s Reckless Disregard for the Truth and Fundamental Misunderstanding of Masimo’s Business Strongly Encourages Stockholders to Protect Their Investment by Voting FOR H Michael Cohen and Julie Shimer, Ph.D., on the WHITE Proxy Card IRVINE, Calif. / Jun 01, 2023... Read More

Masimo’s Leadership Has Delivered Strong Returns for Investors through Sustained Profitable Above-Market Growth Masimo’s Strategy Leverages Core Competencies to Extend Growth in Core and New Markets, Create Value for All Shareholders Masimo’s Board Has Engaged Extensively with Shareholders and Acted on Their Feedback Quentin Koffey’s Unprincipled, Self-Serving Behavior and Dangerous Agenda Jeopardize Masimo’s Long-Term... Read More

Strongly Encourages Stockholders to Protect Their Investment by Voting FOR H Michael Cohen and Julie Shimer, Ph.D., on the WHITE Proxy Card Highlights Track Record of Stockholder Value Creation, Winning Strategy, Positive Governance Changes and Risks to the Company Posed by Quentin Koffey Visit KeepMasimoStrong.com for More... Read More

Secure Masimo Health Data Tracking Now Enabled on 4 Million Devices from Denon, Marantz, and Definitive Technology IRVINE, Calif. / May 24, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced the global expansion of the HEOS platform, enabling an always-on connection to the Masimo Health secure cloud for four million... Read More

IRVINE, Calif. / May 12, 2023 / Business Wire / Micah Young, Chief Financial Officer of Masimo (NASDAQ: MASI), has been awarded CFO of the Year by the Orange County Business Journal (OCBJ) . In presenting the award, Outstanding CFO of a Public Company , at last night’s ceremony in Irvine, OCBJ Publisher Richard Reisman commended Mr. Young for delivering strong shareholder returns, significantly increasing Masimo’s annual... Read More

First Quarter 2023 Highlights Consolidated revenue was $565.0 million; Healthcare revenue was $346.7 million, representing 14.0% reported growth and 15.8% constant currency growth; Non-healthcare revenue was $218.3 million; GAAP earnings per diluted share was $0.39; and Non-GAAP earnings per diluted share was $0.87. IRVINE, Calif. / May 09, 2023 / Business Wire / Masimo (Nasdaq: MASI) today announced its financial results... Read More

NEUCHATEL, Switzerland / May 08, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that Cambridge University Hospitals NHS Foundation Trust, U.K. is adopting the Masimo W1™ advanced health tracking watch for use in its telehealth and telemedicine programs. Masimo W1, which offers accurate, continuous measurements of... Read More

IRVINE, Calif. / May 01, 2023 / Business Wire / Masimo (NASDAQ: MASI), a global leader in pulse oximetry and other innovative noninvasive monitoring technologies, today announced the launch of Stork, a revolutionary home baby monitoring system. This innovative system offers parents insights into their baby’s health data,... Read More

Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET) IRVINE, Calif. / Apr 25, 2023 / Business Wire / Masimo (NASDAQ: MASI) will release first quarter 2023 financial results for the period ended April 1, 2023, after the market closes on Tuesday, May 9, 2023. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer,... Read More

IRVINE, Calif. / Apr 18, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that the Rad-G ® with Temperature has received FDA 510(k) clearance. Rad-G with Temperature is a rugged, versatile, handheld monitor that provides clinically proven SET ® pulse oximetry, respiration rate from the pleth (RRp ® ), and other... Read More

Opioid Halo Is Indicated for the Detection of Opioid-Induced Respiratory Depression, with Escalating Alarms to Alert Loved Ones That Help Is Needed De Novo Authorizes Both Over-the-Counter (OTC) Use, on Adults and Children Age 15 and Up, and Prescription Use IRVINE, Calif. / Apr 03, 2023 / Business Wire / Masimo (NASDAQ: MASI)... Read More

First of Its Kind Smartwatch Combines Masimo’s Accurate, Continuous Health Tracking Technology and Breakthrough Features in a Premium, Elegant Watch IRVINE, Calif. / Mar 28, 2023 / Business Wire / Masimo (NASDAQ: MASI), a global leader in pulse oximetry and innovative noninvasive monitoring technologies, unveiled the newest... Read More

H Michael Cohen Selected as Lead Independent Director Two Additional New Directors to Be Named to Board Following Consultation with Stockholders Significant Governance Changes Announced, Including Termination of Rights Agreement and Plan to Declassify Board IRVINE, Calif. / Mar 23, 2023 / Business Wire / Masimo Corporation (Nasdaq: MASI) today announced changes to its Board of Directors and governance policies, the result of... Read More

NEUCHATEL, Switzerland / Mar 15, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that updated guidelines published by the European Society of Anaesthesiology and Intensive Care (ESAIC) highlight the value of noninvasive, continuous hemoglobin (Hb) monitoring in helping clinicians manage perioperative bleeding. Referencing studies using technologies such as Masimo SpHb ® , the guidelines note that “the use of... Read More

NEUCHATEL, Switzerland / Mar 09, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in Pediatrics International in which Dr. Ya-Fei Liu and colleagues at Peking University First Hospital in Beijing evaluated the ability of noninvasive, continuous Masimo PVi ® , alongside other dynamic parameters, to predict fluid responsiveness in children 1-3 years old who were... Read More

NEUCHATEL, Switzerland / Mar 06, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the British Journal of Neurosurgery in which Dr. Ankita Dey and colleagues at institutions in Bathinda and Pondicherry, India evaluated the use of noninvasive, continuous Masimo PVi ® , as part of goal-directed fluid therapy (GDFT), to guide intraoperative fluid administration during... Read More

IRVINE, Calif. / Mar 02, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that its management will participate in the 44th Annual Raymond James Institutional Investors on Tuesday, March 7, 2023 at 11:00 a.m. Eastern Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo... Read More

NEUCHATEL, Switzerland / Feb 21, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced the findings of a prospective, double-blinded, randomized controlled study published in Medicine in which Dr. Jin Hee Ahn and colleagues at the Sungkyunkwan University School of Medicine in Seoul, Korea, evaluated the ability of Masimo ORi™ to assist clinicians in guiding supplemental oxygenation during elective laparoscopic... Read More

IRVINE, Calif. / Feb 15, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced that Centroid ® , a wearable, wireless patient orientation and activity sensor, has received an Innovative Technology designation from Vizient, Inc. , the largest healthcare performance improvement company in the United States. Masimo exhibited Centroid in combination with the Masimo Root ® Patient Monitoring and Connectivity platform at... Read More

IRVINE, Calif. / Feb 14, 2023 / Business Wire / Masimo (NASDAQ: MASI) will release fourth quarter and FY 2022 financial results for the period ended December 31, 2022, after the market closes on Tuesday, February 28, 2023. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Micah Young, Executive Vice President and... Read More

AI-Based Video Analysis System Promotes Hand Hygiene Compliance, Integrates with Masimo Hospital Automation™ Platform IRVINE, Calif. / Jan 30, 2023 / Business Wire / Masimo (NASDAQ: MASI) today announced the limited market release of Visual Clinical Activity Monitoring (VCAM™), a video analysis system that uses artificial... Read More

Simultaneous Use of Masimo O3 ® Regional Oximetry, NomoLine ® Capnography, SedLine ® Brain Function Monitoring, and rainbow ® Pulse CO-Oximetry Helped Clinicians Determine that Maintaining Higher End-tidal Carbon Dioxide (EtCO 2 ) Improved Cerebral Oxygenation, Leading to Improved Outcomes NEUCHATEL, Switzerland / Jan 23, 2023... Read More

Breakthrough Combination of the Masimo W1 Watch with Advanced Philips Solutions Will Become Available for Home Telehealth Applications Masimo (NASDAQ: MASI) and Royal Philips (NYSE: PHG, AEX: PHIA) today announced an expansion of their partnership to augment patient monitoring capabilities in home telehealth applications with... Read More

A United States Administrative Law Judge in Washington, D.C. ruled that Apple Inc. (Nasdaq: AAPL) violated Section 337 of the Tariff Act of 1930 as amended, by importing and selling within the United States certain Apple Watches with light-based pulse oximetry functionality and components, which infringe one of Masimo’s (Nasdaq: MASI) pulse oximeter patents. Apple first released its pulse oximeter sensor with the Apple Watch... Read More

Masimo SpHb on the Handheld Masimo Rad-67 ® Demonstrated “Acceptable Accuracy and Excellent Correlation” with Laboratory Hemoglobin Masimo (NASDAQ: MASI) today announced the results of a prospective study published in the American Journal of Emergency Medicine in which Dr. Zohair Ahmed Ali Al Aseri and colleagues at King Saud... Read More

Masimo (NASDAQ: MASI) today announced the findings of a before-and-after study published in PLoS ONE in which Dr. Ahmed Balshi and colleagues at King Saud Medical City in Riyadh, Saudi Arabia, evaluated the impact of implementing remote patient monitoring with Masimo Patient SafetyNet™ on the efficacy of hospital rapid... Read More

Masimo ( NASDAQ: MASI) today announced that its management will participate in the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 10:30 a.m. Pacific Time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webcast will be available following the live presentation. About Masimo Masimo (NASDAQ: MASI) is a global medical technology... Read More

Masimo SpHb Demonstrated “Clinically Acceptable Accuracy” of Hemoglobin Measurement, Even at Low Hemoglobin Levels Masimo (NASDAQ: MASI) today announced the findings of a prospective study published in the Egyptian Journal of Anesthesia in which Dr. Mohamed Ibrahim Beleta and colleagues at Cairo University evaluated the... Read More